港股异动 | 信和置业(0083.HK)、中国旺旺(0151.HK)均跌逾3% 遭剔出恒指成份股
格隆汇8月17日丨信和置业(0083.HK)现报9.21港元,跌3.56%,暂成交1.2亿港元,最新总市值648亿港元。中国旺旺(0151.HK)现报5.7港元,跌3.06%,暂成交1.2亿港元,最新总市值707亿港元。恒生指数公司上周五(14日)晚间公布最新一期指数检讨结果,其中,信和置业、中国旺旺、中国神华遭剔出恒生指数成份股。大摩最新发研报指,信和置业遭剔出恒指成份股,估计导致6,400万美元资金流出,约相当于该股14日交易量,故预期其股价短期内受压,未来60天股价跑输大市的机会率高达80%。维持信和置业“与大市同步”评级,目标价11港元。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.